Annual ROE
-61.30%
-3.60%-6.24%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual return on equity is -61.30%, with the most recent change of -3.60% (-6.24%) on April 30, 2024.
- During the last 3 years, KALV annual ROE has fallen by -43.32% (-240.93%).
- KALV annual ROE is now -302.71% below its all-time high of 30.24%, reached on December 31, 2014.
Performance
KALV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-103.92%
-6.55%-6.73%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly return on equity is -103.92%, with the most recent change of -6.55% (-6.73%) on October 31, 2024.
- Over the past year, KALV quarterly ROE has dropped by -11.64% (-12.61%).
- KALV quarterly ROE is now -183.33% below its all-time high of 124.71%, reached on June 30, 2015.
Performance
KALV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KALV ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.2% | -12.6% |
| 3 y3 years | -240.9% | -236.8% |
| 5 y5 years | -82.5% | -309.9% |
KALV ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -240.9% | at low | -232.7% | at low |
| 5 y | 5-year | -240.9% | at low | -236.8% | at low |
| alltime | all time | -302.7% | +93.7% | -183.3% | +77.4% |
KalVista Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | -103.92%(+6.7%) |
| Jul 2024 | - | -97.37%(+5.5%) |
| Apr 2024 | -61.30%(+6.2%) | -92.28%(+7.2%) |
| Jan 2024 | - | -86.06%(+28.2%) |
| Oct 2023 | - | -67.13%(+10.8%) |
| Jul 2023 | - | -60.57%(+6.6%) |
| Apr 2023 | -57.70%(+29.7%) | -56.84%(+6.2%) |
| Jan 2023 | - | -53.53%(+2.2%) |
| Oct 2022 | - | -52.40%(+15.2%) |
| Jul 2022 | - | -45.48%(+19.4%) |
| Apr 2022 | - | -38.08%(+21.9%) |
| Apr 2022 | -44.49%(+147.4%) | - |
| Jan 2022 | - | -31.24%(+1.2%) |
| Oct 2021 | - | -30.86%(-6.4%) |
| Jul 2021 | - | -32.98%(-18.8%) |
| Apr 2021 | -17.98%(-44.3%) | -40.64%(-24.4%) |
| Jan 2021 | - | -53.77%(+13.3%) |
| Oct 2020 | - | -47.44%(+25.8%) |
| Jul 2020 | - | -37.71%(+21.7%) |
| Apr 2020 | -32.26%(-3.9%) | -30.98%(-2.2%) |
| Jan 2020 | - | -31.68%(+25.0%) |
| Oct 2019 | - | -25.35%(-4.4%) |
| Jul 2019 | - | -26.53%(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | -33.58%(-37.8%) | -28.81%(+30.4%) |
| Jan 2019 | - | -22.09%(-31.6%) |
| Oct 2018 | - | -32.31%(-43.2%) |
| Jul 2018 | - | -56.86%(+4.3%) |
| Apr 2018 | -53.96%(-23.4%) | -54.51%(-14.0%) |
| Jan 2018 | - | -63.42%(-7.9%) |
| Oct 2017 | - | -68.89%(+17.1%) |
| Jul 2017 | - | -58.81%(-2.3%) |
| Apr 2017 | -70.44%(+118.1%) | -60.21%(-1.0%) |
| Jan 2017 | - | -60.82%(+20.0%) |
| Sep 2016 | - | -50.70%(-0.1%) |
| Jun 2016 | - | -50.77%(-39.2%) |
| Apr 2016 | -32.30%(-96.7%) | - |
| Mar 2016 | - | -83.47%(-52.9%) |
| Dec 2015 | -968.84%(-3303.8%) | -177.21%(-61.5%) |
| Sep 2015 | - | -459.75%(-468.7%) |
| Jun 2015 | - | 124.71%(+234.0%) |
| Mar 2015 | - | 37.34%(+17.2%) |
| Dec 2014 | 30.24%(+79.6%) | 31.87%(+18.7%) |
| Sep 2014 | - | 26.86%(+54.5%) |
| Jun 2014 | - | 17.38%(+81.8%) |
| Mar 2014 | - | 9.56%(+167.0%) |
| Dec 2013 | 16.84%(+132.0%) | 3.58% |
| Dec 2012 | 7.26% | - |
FAQ
- What is KalVista Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual ROE year-on-year change?
- What is KalVista Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly ROE year-on-year change?
What is KalVista Pharmaceuticals annual return on equity?
The current annual ROE of KALV is -61.30%
What is the all time high annual ROE for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual return on equity is 30.24%
What is KalVista Pharmaceuticals annual ROE year-on-year change?
Over the past year, KALV annual return on equity has changed by -3.60% (-6.24%)
What is KalVista Pharmaceuticals quarterly return on equity?
The current quarterly ROE of KALV is -103.92%
What is the all time high quarterly ROE for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly return on equity is 124.71%
What is KalVista Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, KALV quarterly return on equity has changed by -11.64% (-12.61%)